Tumore al polmone a piccole cellule (ES-SCLC): FDA approva la combinazione lurbinectedina (Zepzelca®) e Atezolizumab (Tecentriq®) come terapia di mantenimento di prima linea
PharmaMar (MSE:PHM) ha annunciato che la Food and Drug Administration (FDA) statunitense ha concesso l’approvazione per Zepzelca® (lurbinectedina) in combinazione con atezolizumab (Tecentriq®) come trattamento di mantenimento per adulti con…
FDA approves PharmaMar’s Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination as First-line Maintenance Therapy for Extensive-stage Small Cell Lung Cancer
harmaMar (MSE:PHM) has announced that the U.S Food and Drug Administration (FDA) has granted approval for Zepzelca® (lurbinectedin) in combination with atezolizumab (Tecentriq®) as a maintenance treatment for adults with…
The diamonds that could find cancer
University of Warwick researchers have built a new diamond-based magnetic field sensor that could be used to better find tumours through tracing magnetic fluid injected in the body. A cancer…
Genetic testing reduces risks from chemotherapy for gastrointestinal cancer patients
For some patients with gastrointestinal (GI) cancers like colorectal and pancreatic cancer, chemotherapy can cause severe, sometimes life-threatening side effects in those who carry certain genetic variants that can impact…
“AI platform” designs molecular missiles to attack cancer cells
Precision cancer treatment on a larger scale is moving closer after researchers have developed an AI platform that can tailor protein components and arm the patient’s immune cells to fight…
A new blood test may detect leukemia risk and replace bone marrow sampling
What if a blood test could reveal the pace of our aging – and the diseases that may lie ahead? The labs of Profs. Liran Shlush and Amos Tanay at…
Hereditary Mutations in BRCA Genes Increase Risk of Rare Lymphoma Among Women with Breast Cancer Who Received Textured Breast Implants
Women with breast cancer who were also carriers of the BRCA1 or BRCA2 mutation and received textured breast implants as part of their reconstructive surgery after mastectomy were 16 times…
Colon cancer survivors: movement is medicine and reduces the risk of cancer recurrence and death #ASCO25
New study results show that a structured exercise program following surgery and adjuvant chemotherapy reduced the risk of recurrent or new cancer and increased survival for patients with stage III…
Alcohol-fueled cancer deaths are on the rise in the US #ASCO25
A new study led by experts at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, is the first to look at trends over time…
Budget request would stunt U.S. cancer research and risk future advances in cancer care #ASCO25
Today the administration released the details of its proposed FY 2026 budget request, including a nearly 40% reduction in funding for the National Institutes of Health (NIH) and the National…